Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Fidalgo-Zapata"'
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207224 (2018)
Response to neoadjuvant chemotherapy in breast cancer patients is of prognostic value in determining short- and mid-term outcomes. Inflammatory biomarkers, such as platelet-to-lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR), have been
Externí odkaz:
https://doaj.org/article/3848ddcfcd134e53a23945f9a6894ab6
Publikováno v:
International Journal of Breast Cancer, Vol 2017 (2017)
Introduction. Obesity is an established risk factor for cancer and cancer-related deaths, including that of the breast. While the prevalence of female obesity has accelerated over the past decade in many developing countries, such as Colombia, the pr
Externí odkaz:
https://doaj.org/article/852d89a6baba49de9368c3bfe6227cc2
Autor:
Elsa Maria Vasquez-Trespalacios, Javier Cuello-López, Laura López-Agudelo, Ana Fidalgo-Zapata
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 11, p e0207224 (2018)
PLoS ONE, Vol 13, Iss 11, p e0207224 (2018)
Response to neoadjuvant chemotherapy in breast cancer patients is of prognostic value in determining short- and mid-term outcomes. Inflammatory biomarkers, such as platelet-to-lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR), have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abfd84e3928b9d5d0cacc594e899925
https://pubmed.ncbi.nlm.nih.gov/30427884
https://pubmed.ncbi.nlm.nih.gov/30427884